Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody
- PMID: 6935296
Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody
Abstract
Modulation of a human common acute lymphoblastic leukemia antigen (CALLA) by specific monoclonal antibody (J5) has been studied with the immune precipitation method to identify radiolabeled antigen. Surfaces of leukemic cells have been labeled using 125I both before and after modulation by J5 antibody for different time intervals. Leukemic cells have also been metabolically labeled with 35S-methionine before modulation. These studies indicate that the 100,000-dalton glycoprotein expressing CALLA (gp 100-CALLA) cannot be detected in cells that were modulated with J5 antibody before surface labeling but that it is easily detectable in cells that were surface labeled before modulation for 10 hr. At later time points, gp 100-CALLA is selectively lost from cells that were surface labeled before modulation. Gp 100-CALLA is not detected in the supernatants from cultures of these modulated cells. We conclude that gp 100-CALLA is rapidly internalized during modulation and that CALLA is degraded. Gp 100-CALLA is not shed into the culture media, nor does it remain on the cell surface in an altered form. Incubation of leukemic cells with antisera to beta2-microglobulin or IgM does not affect the expression of gp 100-CALLA.
Similar articles
-
Distribution and modulation of a human leukemia-associated antigen (CALLA).J Immunol. 1983 Oct;131(4):2038-45. J Immunol. 1983. PMID: 6225802
-
Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.J Immunol. 1986 Jan;136(1):320-5. J Immunol. 1986. PMID: 2415623
-
Unique epitopes of common acute lymphoblastic leukemia antigen detected by new monoclonal antibodies.Cancer Res. 1987 Apr 15;47(8):2160-6. Cancer Res. 1987. PMID: 2435407
-
Antibody-targeted therapy for myeloid leukemia.Semin Hematol. 1999 Oct;36(4 Suppl 6):2-8. Semin Hematol. 1999. PMID: 10530710 Review.
-
[Membrane markers of lymphoid cells in immunoproliferative diseases of man].Z Gesamte Inn Med. 1980 Jan 15;35(2):66-9. Z Gesamte Inn Med. 1980. PMID: 6996351 Review. German.
Cited by
-
Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens.Immunology. 1985 Jun;55(2):331-8. Immunology. 1985. PMID: 2861156 Free PMC article.
-
Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy.Cancer Immunol Immunother. 1983;14(3):155-66. doi: 10.1007/BF00205354. Cancer Immunol Immunother. 1983. PMID: 6188529 Free PMC article.
-
Radioimmunotherapy in mantle cell lymphoma.Best Pract Res Clin Haematol. 2012 Jun;25(2):201-10. doi: 10.1016/j.beha.2012.04.004. Epub 2012 May 9. Best Pract Res Clin Haematol. 2012. PMID: 22687456 Free PMC article. Review.
-
Biological therapy of cancer.Breast Cancer Res Treat. 1986;7(1):5-14. doi: 10.1007/BF01886730. Breast Cancer Res Treat. 1986. PMID: 3516264 Clinical Trial.
-
Clearance of antibodies from rat sarcoma cell surfaces. Rate of clearance of alloantibodies depends on antibody isotype.Immunology. 1983 Dec;50(4):565-73. Immunology. 1983. PMID: 6654388 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical